Abstract
Conclusion:
Elevated levels of IMA and IMAR in HEG patients might be due to ischemic intrauterine environment.
Results:
Serum median IMA levels [0.55 (0.43-0.68)] was found to be elevated in HEG patients compared with pregnant [0.52 (0.34-0.61)] and non-pregnant controls [0.48 (0.27-0.57)] (p=˂0.001). IMAR levels were also found to be significantly elevated in HEG patients compared to both control groups. According to correlation analysis, IMA and IMAR levels were only correlated with C-reactive protein levels.
Methods:
One patient group and two control groups were constituted. Pregnant subjects with HEG were included in HEG group (n = 31) and age-, gestational age-, and body mass index (BMI)-matched healthy pregnant women in control group (n = 30). The second control group was constituted from age- and BMI-matched non-pregnant women (n=30). Serum IMA, IMAR blood glucose, albumin, urea, creatinine, alanine aminotransferase and aspartate aminotransferase levels were measured in all subjects.
Aim:
Hyperemesis gravidarum (HEG) is characterized by severe nausea and vomiting, weight loss and nutritional deficiency. Although exact cause of this condition is still a matter of debate, contribution of oxidative stress to pathogenesis of HEG was demonstrated in some studies. The aim of this study was to investigate the diagnostic value of ischemia-modified albumin (IMA) concentration and IMA/albumin ratio (IMAR) in HEG patients.
Keywords: Hyperemesis gravidarum, ischemia-modified albumin, ischemia-modified albumin/albumin ratio, oxidative stress
References
Biberoglu EH, Kirbas A, Dirican AÖ, et al. Alterations in lipid peroxidation and T-cell function in women with hyperemesis gravidarum. J Obstet Gynaecol 2016;36:93-6.
Ismail SK, Kenny L. Review on hyperemesis gravidarum. Best Pract Res Clin Gastroenterol 2007;21:755-69.
Li L, Li L, Zhou X, Xiao S, Gu H, Zhang G. Helicobacter pylori Infection Is Associated with an Increased Risk of Hyperemesis Gravidarum: A Meta-Analysis. Gastroenterol Res Pract 2015;2015:278905.
Sun S, Qiu X, Zhou J. Clinical analysis of 65 cases of hyperemesis gravidarum with gestational transient thyrotoxicosis. J Obstet Gynaecol Res 2014;40:1567-72
Verberg MF, Gillott DJ, Al-Fardan N, Grudzinskas JG. Hyperemesis gravidarum, a literature review. Hum Reprod Update 2005;11:527-39.
Onaran Y, Kafali H, Duvan Cİ, Keskin E, Celik H, Erel O. Relationship between oxidant and antioxidant activity in hyperemesis gravidarum. J Matern Fetal Neonatal Med 2014;27:825-8.
Sari N, Ede H, Engin-Ustun Y, Göçmen AY, Çağlayan EK. Hyperemesis gravidarum is associated with increased maternal serum ischemia-modified albumin. J Perinat Med 2017;45:421-5.
Fait V, Sela S, Ophir E, et al. Hyperemesis gravidarum is associated with oxidative stress. Am J Perinatol 2002;19:93-8.
Tunc SY, Agacayak E, Budak S, et al. Serum levels of neopterin, inflammatory markers and oxidative stress indicators in hyperemesis gravidarum. J Obstet Gynaecol Res 2016;42:618-24.
Turan T, Akyüz AR, Sahin S, et al. Association between the plasma levels of IMA and coronaryatherosclerotic plaque burden and ischemic burden in early phase of non-ST-segment-elevation acute coronary syndromes. Eur Rev Med Pharmacol Sci 2017;21:576-83.
Shen XL, Lin CJ, Han LL, Lin L, Pan L, Pu XD. Assessment of ischemia-modified albumin levels for emergency room diagnosis of acute coronary syndrome. Int J Cardiol 2011;149:296-8.
Sinha MK, Roy D, Gaze DC, Collinson PO, Kaski JC. Role of “Ischemia modified albumin”, a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 2004;21:29-34.
Abboud H, Labreuche J, Meseguer E, et al. Ischemia-modified albumin in acute stroke. Cerebrovasc Dis 2007;23:216-20.
Gunduz A, Turedi S, Mentese A, et al. Ischemia-modified albumin in the diagnosis of acute mesenteric ischemia: a preliminary study. Am J Emerg Med 2008;26:202-5.
Can Ü, Yosunkaya Ş. İskemide yeni bir marker: İskemi modifiye albumin. Koşuyolu Heart J 2017;20:148-52.
Cakir M, Karahan SC, Mentese A, et al. Ischemia-modified albumin levels in children with chronic liver disease. Gut Liver 2012;6:92-7.
Chen CY, Tsai WL, Lin PJ, Shiesh SC. The value of serum ischemia-modified albumin for assessing liver function in patients with chronic liver disease. Clin Chem Lab Med 2011;49:1817-21.
Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med 2000;19:311-5.
Dusek J, St’ásek J, Tichý M, et al. Prognostic significance of ischemia modified albumin after percutaneous coronary intervention. Clin Chim Acta 2006;367:77-80.
Bhagavan NV, Lai EM, Rios PA, et al. Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction. Clin Chem 2003;49:581-5.
Prefumo F, Gaze DC, Papageorghiou AT, Collinson PO, Thilaganathan B. First trimester maternal serum ischaemia-modified albumin: a marker of hypoxia-ischaemia-driven early trophoblast development. Hum Reprod 2007;22:2029-32.
Ustün Y, Engin-Ustün Y, Oztürk O, Alanbay I, Yaman H. Ischemia-modified albumin as an oxidative stress marker in preeclampsia. J Matern Fetal Neonatal Med 2011;24:418-21.
Iacovidou N, Briana DD, Boutsikou M, et al. Cord blood ischemia-modified albumin levels in normal and intrauterine growth restricted pregnancies. Mediators Inflamm 2008;2008:523081.
Yarcı Gursoy A, Caglar GS, Demirtas S. Ischemia modified albumin in perinatology. Eur J Obstet Gynecol Reprod Biol 2017;210:182-8.
Than NN, Neuberger J. Liver abnormalities in pregnancy. Best Pract Res Clin Gastroenterol 2013;27:565-75.
2 Jamjute P, Ahmad A, Ghosh T, Banfield P. Liver function test and pregnancy. J Matern Fetal Neonatal Med 2009;22:274-83.
Lee NM, Brady CW. Liver disease in pregnancy. World J Gastroenterol 2009;15:897-906.
D’souza JM, Pai VR, Harish S, Shriyan C, D’souza N. IMA and IMAR in serum and saliva of preeclampsia--a preliminary study. Hypertens Pregnancy 2014;33:440-8.
Ellidag HY, Eren E, Yılmaz N, Cekin Y. Oxidative stress and ischemia-modified albumin in chronic ischemic heart failure. Redox Rep 2014;19:118-23.
Türkön H, Gökmen F, Çakir DÜ, et al. Increased Levels of Serum Ischemia Modified Albumin in Patients with Ankylosing Spondylitis. Clin Lab 2016;62:645-9.
Verit FF, Erel O, Celik H. Paraoxonase-1 activity in patients with hyperemesis gravidarum. Redox Rep 2008;13:134-8.
Kurt RK, Güler A, Silfeler DB, Ozçil MD, Karateke A, Hakverdi AU. Relation of inflammatory markers with both presence and severity of hyperemesis gravidarum. Ginekol Pol 2014;85:589-93.
Yoneyama Y, Suzuki S, Sawa R, Araki T. Plasma adenosine concentrations increase in women with hyperemesis gravidarum. Clin Chim Acta 2005;352:75-9.
Kaplan PB, Gücer F, Sayin NC, Yüksel M, Yüce MA, Yardim T. Maternal serum cytokine levels in women with hyperemesis gravidarum in the first trimester of pregnancy. Fertil Steril 2003;79:498-502.
Engin-Ustun Y, Tonguç E, Var T, et al. Vaspin and C-reactive protein levels in hyperemesis gravidarum. Eur Rev Med Pharmacol Sci 2013;17:138-40.
